Manatuck Hill Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,000
Closed -$396K 97
2022
Q4
$396K Buy
+8,000
New +$327K 0.19% 75
2014
Q2
Sell
-228,231
Closed -$3.23M 98
2014
Q1
$3.23M Sell
228,231
-214,300
-48% -$2.89M 0.51% 45
2013
Q4
$5.2M Buy
+442,531
New +$5.08M 0.73% 35

Other funds holding EXAS

Manatuck Hill Partners's EXAS Position: Q1 2023 in Review

Manatuck Hill Partners sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 8,000 shares — an estimated $396K sold.

Manatuck Hill Partners first reported a position in EXAS in Q4 2013 and held it in 3 quarters. The position peaked at $5.2M in Q4 2013. 584 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Manatuck Hill Partners reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Manatuck Hill Partners sold 8,000 Exact Sciences shares in Q1 2023, an estimated $396K.
  • Manatuck Hill Partners first reported a position in Exact Sciences in Q4 2013 and held it in 3 quarters.
  • Manatuck Hill Partners's Exact Sciences position peaked at $5.2M in Q4 2013.
  • 584 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Manatuck Hill Partners's 13F filing for Q1 2023, filed 15 May 2023.